Skip to main navigation Skip to search Skip to main content

Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis

  • Ben Gold
  • , Robert Smith
  • , Quyen Nguyen
  • , Julia Roberts
  • , Yan Ling
  • , Landys Lopez Quezada
  • , Selin Somersan
  • , Thulasi Warrier
  • , David Little
  • , Maneesh Pingle
  • , David Zhang
  • , Elaine Ballinger
  • , Matthew Zimmerman
  • , Véronique Dartois
  • , Paul Hanson
  • , Lester A. Mitscher
  • , Patrick Porubsky
  • , Steven Rogers
  • , Frank J. Schoenen
  • , Carl Nathan
  • Jeffrey Aubé
  • Cornell University
  • University of Kansas
  • University of North Carolina at Chapel Hill

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Abstract

We report two series of novel cephalosporins that are bactericidal to Mycobacterium tuberculosis alone of the pathogens tested, which only kill M. tuberculosis when its replication is halted by conditions resembling those believed to pertain in the host, and whose bactericidal activity is not dependent upon or enhanced by clavulanate, a β-lactamase inhibitor. The two classes of cephalosporins bear an ester or alternatively an oxadiazole isostere at C-2 of the cephalosporin ring system, a position that is almost exclusively a carboxylic acid in clinically used agents in the class. Representatives of the series kill M. tuberculosis within macrophages without toxicity to the macrophages or other mammalian cells.

Original languageEnglish
Pages (from-to)6027-6044
Number of pages18
JournalJournal of Medicinal Chemistry
Volume59
Issue number13
DOIs
StatePublished - 14 Jul 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis'. Together they form a unique fingerprint.

Cite this